Form 4 for MIRM Mirum Pharmaceuticals, Inc.
Accepted 2024-02-05 00:00:00 ET · period of report 2024-02-02 · accession 0001415889-24-002756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-05 | 2024-02-02 | MIRM | Longpre Lara | Chief DEVELOPMENT Off | S - Sale | $26.19 | -847 | 104.4K | -0.8% | -$22.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-02 | S | D | 847 | $26.19 | 104,407 | D | — | — |